SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from Hoth Therapeutics, Inc. (HOTH) (CIK 0001711786) (RKTO) — Feb 6, 2019

Hoth Therapeutics, Inc. (HOTH) (CIK 0001711786)
Date: Feb. 6, 2019 · CIK: 0001711786 · Accession: 0001615774-19-002005

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-227772

Date
Feb. 6, 2019
Author
Robb Knie
Form
CORRESP
Company
Hoth Therapeutics, Inc. (HOTH) (CIK 0001711786)

Letter

Hoth Therapeutics, Inc.

Rockefeller Plaza, Suite 1039

New York, New York 10020

February 6, 2019

VIA EDGAR

United States Securities and Exchange Commission

F Street, N.E.

Washington, D.C. 20549

Attention: Effie Simpson

Doug Jones

Julie Griffith

Susan Block

Re: Hoth Therapeutics, Inc.

Registration Statement on Form S-1, as amended

File No. 333-227772

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), Hoth Therapeutics, Inc. (the “Company”) respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 5:00 p.m., Eastern Standard Time, on Monday February 11, 2019, or as soon thereafter as possible.

Please notify Richard Friedman of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (212) 634-3031 as soon as possible as to the time the Registration Statement has been declared effective pursuant to this acceleration request.

Thank you,

HOTH THERAPEUTICS, INC.

By: /s/ Robb Knie

Name: Robb Knie

Title: Chief Executive Officer

Show Raw Text
CORRESP
1
filename1.htm

Hoth
Therapeutics, Inc.

1
Rockefeller Plaza, Suite 1039

New
York, New York 10020

February
6, 2019

VIA
EDGAR

United
States Securities and Exchange Commission

100
F Street, N.E.

Washington,
D.C. 20549

Attention:  Effie
Simpson

Doug
Jones

Julie
Griffith

Susan
Block

 Re: Hoth
Therapeutics, Inc.

Registration
Statement on Form S-1, as amended

File
No. 333-227772

Ladies
and Gentlemen:

Pursuant
to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), Hoth Therapeutics,
Inc. (the “Company”) respectfully requests that the effective date of the registration statement referred to above
be accelerated so that it will become effective at 5:00 p.m., Eastern Standard Time, on Monday February 11, 2019, or as soon
thereafter as possible.

Please
notify Richard Friedman of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (212) 634-3031 as soon
as possible as to the time the Registration Statement has been declared effective pursuant to this acceleration request.

    Thank you,

    HOTH THERAPEUTICS, INC.

    By:
    /s/ Robb Knie

    Name: Robb Knie

    Title: Chief Executive Officer